Norovirus Treatment Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 What is the current market size of the norovirus treatment industry, and what growth rate is it expected to achieve?
 The norovirus treatment market size has grown rapidly in recent years. It will grow from $1.75 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising global norovirus outbreaks, an increase in public awareness, a growing focus on supportive care, investment in vaccine research, improving healthcare infrastructure, and heightened demand for effective infection control measures.
 
 The norovirus treatment market size is expected to see rapid growth in the next few years. It will grow to $2.91 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing funding for antiviral drug development, rising adoption of rapid diagnostic tools, growing awareness of norovirus-related public health impacts, expanding healthcare access in emerging economies, and the development of novel supportive therapies targeting symptom severity. Major trends in the forecast period include advancements in vaccine development, innovative antiviral therapies, improved molecular diagnostic technologies, adoption of AI-driven diagnostic tools, enhanced public health campaigns, and development of cost-effective point-of-care treatment solutions.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24629&type=smp
  
 What are the major drivers contributing to the growth of the norovirus treatment market?
 The increasing prevalence of infectious disease is expected to propel the growth of the norovirus treatment market going forward. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites that spread between people and include influenza, tuberculosis, HIV/AIDS, malaria, and norovirus. Infectious disease is increasing due to urban overcrowding, which facilitates faster transmission of pathogens among densely packed populations. Norovirus treatment helps reduce the impact of infectious disease by managing symptoms effectively and limiting the spread through proper hydration, hygiene, and isolation practices. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, an estimated 10.8 million individuals, comprising 6.0 million men, 3.6 million women, and 1.3 million children, contracted tuberculosis globally in 2023. Therefore, the increasing prevalence of infectious disease is driving growth of the norovirus treatment market.
 
 What are the major market segments driving the growth of the norovirus treatment industry?
 The norovirus treatment market covered in this report is segmented –
 
 1) By Treatment: Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments
 2) By Diagnosis: Bacteria Culture Test, Stool Tests, Other Diagnosis
 3) By Route Of Administration: Oral, Intravenous, Subcutaneous
 4) By End User: Hospitals, Clinics, Homecare Settings
 
 Subsegments:
 1) By Electrolytes: Oral Rehydration Salts (ORS), Sports Drinks, Pediatric Electrolyte Solutions
 2) By Intravenous Fluids: Crystalloids, Colloids, Lactated Ringer’s Solution
 3) By Antipyretics: Acetaminophen (Paracetamol), Ibuprofen, Aspirin
 4) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen-Based Analgesics
 5) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Diphenoxylate-Atropine
 6) By Other Treatments: Antiemetics, Probiotics, Zinc Supplements
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/norovirus-treatment-global-market-report
 
 What are the key trends shaping the norovirus treatment market in the forecast period?
 Major companies operating in the norovirus treatment market are focusing on developing innovative solutions, such as advanced mRNA vaccines, to accelerate the development of targeted immunization, enhance protection against severe infections, and reduce the global burden of norovirus-related illnesses. Advanced mRNA vaccines are next-generation immunizations that use specially engineered messenger RNA to instruct cells to produce specific proteins, triggering a targeted immune response with improved stability, efficacy, and adaptability against various infectious diseases. For instance, in October 2024, Moderna Inc., a US-based biotechnology company, partnered with the UK Health Security Agency (UKHSA), a UK-based government agency, and launched the world’s first Phase 3 trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This trial introduces a vaccine designed to target the highly contagious norovirus by instructing the body to produce viral proteins that stimulate a strong immune response without using the live virus. Unique features of the launch include its use of stabilized mRNA for improved durability, rapid development potential in response to evolving strains, and the ability to induce both antibody and T-cell responses.
 
 Who are the key market players contributing to the growth of the norovirus treatment industry?
 Major companies operating in the norovirus treatment market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Lupin Ltd., Aurobindo Pharma Limited, Cipla Inc., Endo International plc.
 
 Which regions are leading the growth of the norovirus treatment market globally?
 North America was the largest region in the norovirus treatment market in 2024. The regions covered in the norovirus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Norovirus Treatment Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24629
 
 Need Customized Data On Norovirus Treatment Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=24629&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Americas +1 310–496-7795
 Asia +44 2071930708
 Europe +44 7882 955267
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company